- 30+ sponsored clinical Trials (Phases 1-4) at UPMC IMCPL shady side HCC. Operation includes apheresis and product receipt, processing, storage, and delivery of immune effector cells,
- Receipt, storage, and delivery of 7 licensed CGTs for infusion.
- Oversight for Clinical Development for 8 Investigational Clinical Trials with approved INDs in cancer and regenerative medicine at UPMC IMCPL, Riviera. Includes technology, process and product development, QA, and QC cell, gene and tissue-based advanced investigational therapies (e.g., TILs, Dendritic cells, TCR, stem cells, adipose grafts);
- Immune monitoring tests for clinical trials
Current Grant Support
Review our extensive grant support, source, duration, and amount.
Research Resources
UPMC Hillman Cancer Center was among the first in the nation to offer the FDA-approved CAR T-cell therapies
Success Stories
Read documented success stories.